Zyn scrutiny from Sen. Schumer prompts unlikely culture war

After Sen. Chuck Schumer raised concerns about Zyn nicotine pouches, conservatives sounded off. What could the government actually do?

January 25, 2024 Check out STAT+

Sponsored By

Wikimedia Commons Zyn scrutiny from Sen. Chuck Schumer prompts an unlikely culture war Zyn users tout health benefits of nicotine after top Democrat raises health, addiction concerns. Republicans say it's a "personal freedom issue." By Nicholas Florko Merck CEO refused to testify in Senate because he's not an expert in drug pricing, Bernie Sanders says Merck told Sen. Bernie Sanders' staff that CEO Robert Davis shouldn't testify because he's a tax attorney without expertise in drug prices. By Rachel Cohrs STAT+ | As biotech VCs struggle to raise money, some debate whether the worst is over Venture capitalists are having a harder time raising funds, as biotech investors ask for more. "A lot is changing in venture fundraising right now." By Allison DeAngelis Evangeline Gallagher/TBIJ 'The response defies belief': Year of inaction leaves children at risk from bad cancer drugs A dozen brands of asparaginase, a childhood chemotherapy drug, failed quality tests, but the WHO has yet to issue a global product alert. By Rosa Furneaux and Laura Margottini — TBIJ HPV vaccine study finds zero cases of cervical cancer among women vaccinated before age 14 No cervical cancer cases were detected in Scotland in women born between 1988-1996 and fully vaccinated against HPV between ages 12 to 13, study says. By Annalisa Merelli Transgender women's higher risk for HIV is influenced by discrimination, CDC finds A CDC report points to the high levels of marginalization that trans women face as potential factors in the group's higher risk for HIV. By Theresa Gaffney and Annalisa Merelli Listen: The plight of the VC, Gilead's latest setback, & more M&A In this episode of "The Readout LOUD," we take a look at Gilead Sciences' struggle to turn itself into an oncology company. By Damian Garde and Allison DeAngelis and Adam Feuerstein STAT+ | Key Senate panel considers Medicare bonuses for hospitals that prevent drug shortages A key Senate committee wants Medicare to pay hospitals and doctors bonuses for preventing drug shortages. By John Wilkerson

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser